Cervical Myelopathy in Hip Fracture Patients
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip frac
| Condition(s) | Cervical Myelopathy, Hip Fractures |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated. |
| Who can participate | Inclusion Criteria: * Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall. Exclusion Criteria: * Neurologic or cognitive disorder explaining the fall (dementia, Parkinson's disease, delirium, etc.) * Syncopal fall or fall caused by stroke or a heart condition |
| Ages | 50 Years |
| Sex | All |
| Lead sponsor | Indiana University |
| Locations | Fishers, Indiana, United States; Indianapolis, Indiana, United States; Indianapolis, Indiana, United States |
| Start date | 2025-05-01 |
| NCT ID | NCT06893406 |
| Official listing | https://clinicaltrials.gov/study/NCT06893406 |